Coronaviruses

Cards (48)

  • SARS-CoV-2
    Severe Acute Respiratory Syndrome Coronavirus 2
  • Dr Muhammad Munir
    Email: muhammad.munir@lancaster.ac.uk, Phone: 01524 595083, Office: Furness B69
  • Learning objectives
    • Introduction to coronaviruses and history of common respiratory coronaviruses
    • Molecular biology of coronaviruses
    • Origin of coronaviruses especially SARS-CoV-2
    • Entry and molecular replication
    • Viral pathogenesis
    • Mutants/variants
    • Diagnosis
    • Vaccines
    • Therapeutics
    • Immunity against SARS-COV-2
  • Sands P et al. N Engl J Med 2016;374:1281-1287. Major Emerging and Reemerging Infectious Diseases: Beyond COVID-19
  • First coronavirus discovered (IBV)
    1931
  • Discovery of HCoV-229E
    1966
  • Discovery of HCoV-OC43
    1967
  • Polyprotein processing

    1986
  • Full genome sequenced
    1987
  • Targeted recombination
    1992
  • Reverse genetics

    1995
  • EM of memb. vesicle
    2000
  • SARS-COV Pandemic
    2002
  • Discovery of HCoV-NL63
    2003
  • Discovery of HCoV-HKU1
    2004
  • MERS-COV Pandemic
    2005
  • SARS-COV-2 Pandemic
    2008
  • SARS-COV-2 Pandemic
    2019
  • SARS-COV-2 Pandemic
    2020
  • Coronaviruses Family
    • Nidovirales
    • Coronaviridae
    • Coronavirinae
    • Torovirinae
    • Torovirus
    • Bafinivirus
    • Alphacoronavirus
    • Betacoronavirus
    • Gammacoronavirus
    • Deltacoronavirus
  • More than 500 CoVs have been identified in bats in China, with estimates of unknown bat CoV diversity reaching >5000
  • SARS: 80098 cases, 774 total deaths (epidemic ended) (~1% case fatality)
  • MERS: 2521 cases, 866 total deaths (infections still occurring) (35% case fatality rate)
  • SARS-CoV-1/SARS
    Spillover reservoir unknown: civet cats-cull to break the chain
  • SARS-CoV-2/CoVID-19
    Spillover reservoir unknown, Widespread community transmission, Possible abundant asymptomatic/mild cases
  • SARS-CoV-2 Comparison with other Human Coronaviruses
  • SARS-COV-2 Genome
    Encodes for 27 genes which are either: Structural, Non-structural, Accessory proteins
  • SARS-COV-2 Genome
    • Single-stranded, non-segmented, positive sense, ~30 kb long genome
  • Discontinuous replication
    Bases for Diagnostics, CoV undergo discontinuous transcription, leading to high recombination rates
  • Error rate for RNA replication
    Reduced by proof reading Enzyme ExoN (NSP14)
  • Functions of Coronavirus Virion and Viral Proteins
    • S protein: Entry of SARS-COV-2 into cells, Host tropism, Protective immune responses (vaccines), Virulence
    • N protein: Component of nucleocapsid, Virus transcription efficiency, Protective immune responses (vaccines)
    • M protein: Most abundant amongst structural proteins, Assembly of virus particles
    • E protein: Smallest amongst all the structural proteins, Virus assembly, and release
  • Internal fusion peptide (IFP) S2'
    Gate to Entry in the Cell: Cleavability and Receptor Interaction
  • Omicron Variant
  • Delta Variant
  • Mechanism of SARS-CoV-2 Viral Entry
    1. Fusion
    2. Replication
    3. Assembly
    4. Release
  • Mutations in the RBD of Spike proteins determine: New variants, Transmissibility, Virulence, Vaccine escape
  • Innate Immunity against SARS-COV-2
    Dexamethasone (Discovery Trial)
  • Delta vs Omicron Variants: Delta variant, Omicron variant (70x)
  • Adaptive Immunity against SARS-COV-2
    • CD+ T cells: Helpers
    • Antibodies (from B cells)
    • CD8 T cells: Killers
  • SARS-COV-2 causes acute infections that resolve/cure in most humans (~innate immunity)